Donepezil-Loaded Nanocarriers for the Treatment of Alzheimer’s Disease: Superior Efficacy of Extracellular Vesicles Over Polymeric Nanoparticles

References

• Gauthier S, Rosa-Neto P, Morais J, Webster C. World Alzheimer report 2021: journey through the diagnosis of dementia. Alzheimer’s Dis Int. 2021;2021:30.
   Google Scholar
• S. Schneider L. A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer’s disease. Dial Clin Neurosci. 2000;2(2):111–128. doi:10.31887/DCNS.2000.2.2/lschneider
   PubMedGoogle Scholar
• Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Research Support, Non-U.S. Gov’t. Review. Brain. 2018;141(7):1917–1933. doi:10.1093/brain/awy132
   PubMed Web of Science ®Google Scholar
• Massoud F, Gauthier S. Update on the pharmacological treatment of Alzheimer’s disease. Curr Neuropharmacol. 2010;8(1):69–80. doi:10.2174/157015910790909520
   PubMed Web of Science ®Google Scholar
• Perneczky R, Jessen F, Grimmer T, et al. Anti-amyloid antibody therapies in Alzheimer’s disease. Brain. 2023;146(3):842–849. doi:10.1093/brain/awad005
   PubMed Web of Science ®Google Scholar
• Richard E, den Brok MG, van Gool WA. Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer’s disease. Alzheimer’s Dementia. 2021;17(6):1051–1055. doi:10.1002/alz.12379
   PubMed Web of Science ®Google Scholar
• Wilkinson DG. The pharmacology of donepezil: a new treatment for Alzheimer’s disease. Expert Opinion Pharmacother. 1999;1(1):121–135. doi:10.1517/14656566.1.1.121
   PubMedGoogle Scholar
• Eissa KI, Kamel MM, Mohamed LW, Kassab AE. Development of new Alzheimer’s disease drug candidates using donepezil as a key model. Arch Pharm. 2022;356(1):e2200398. doi:10.1002/ardp.202200398
   PubMed Web of Science ®Google Scholar
• Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer’s disease. Br. J. Pharmacol. 2017;174(23):4224–4232. doi:10.1111/bph.14030
   PubMed Web of Science ®Google Scholar
• Noh MY, Koh SH, Kim SM, Maurice T, Ku SK, Kim SH. Neuroprotective effects of donepezil against A β42‐induced neuronal toxicity are mediated through not only enhancing PP 2 A activity but also regulating GSK‐3β and n AChR s activity. J Neurochem. 2013;127(4):562–574. doi:10.1111/jnc.12319
   PubMed Web of Science ®Google Scholar
• Asiri YA, Mostafa GA. Donepezil. In: Profiles of Drug Substances, Excipients and Related Methodology. Elsevier; 2010:117–150.
   Google Scholar
• Shin CY, Kim H-S, Cha K-H, et al. The effects of donepezil, an acetylcholinesterase inhibitor, on impaired learning and memory in rodents. Biomolecules Ther. 2018;26(3):274. doi:10.4062/biomolther.2017.189
   PubMed Web of Science ®Google Scholar
• Marcantonio ER, Palihnich K, Appleton P, Davis RB. Pilot randomized trial of donepezil hydrochloride for delirium after Hip fracture. J Am Geriatr Soc. 2011;59:S282–S288.
   PubMed Web of Science ®Google Scholar
• Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61(4):479–486. doi:10.1212/01.WNL.0000078943.50032.FC
   PubMed Web of Science ®Google Scholar
• Carrasco MM, Agüera L, Gil P, Moríñigo A, Leon T. Safety and effectiveness of donepezil on behavioral symptoms in patients with Alzheimer disease. Alzheimer Dis Associated Disord. 2011;25(4):333–340. doi:10.1097/WAD.0b013e318212ab7a
   PubMed Web of Science ®Google Scholar
• Chamundeeswari M, Jeslin J, Verma ML. Nanocarriers for drug delivery applications. Environ Chem Lett. 2019;17(2):849–865. doi:10.1007/s10311-018-00841-1
   Web of Science ®Google Scholar
• Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine. 2011;6(4):715–728. doi:10.2217/nnm.11.19
   PubMed Web of Science ®Google Scholar
• Niemeyer CM. Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science. Angew Chem Int Ed. 2001;40(22):4128–4158. doi:10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 2012;8(2):147–166. doi:10.1016/j.nano.2011.05.016
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnol. 2015;33(9):941–951. doi:10.1038/nbt.3330
   PubMed Web of Science ®Google Scholar
• Li G, Zhao M, Xu F, et al. Synthesis and biological application of polylactic acid. Review. Molecules. 2020;25(21):5023. doi:10.3390/molecules25215023
   PubMed Web of Science ®Google Scholar
• Rabanel JM, Faivre J, Paka GD, Ramassamy C, Hildgen P, Banquy X. Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: toward a drug delivery nano-platform to the CNS. Comparative Study. Research support, Non-U.S. Gov’t. Eur J Pharm Biopharm. 2015;96:409–420. doi:10.1016/j.ejpb.2015.09.004
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng SS. Nanoparticles of poly (D, L‐lactide)/methoxy poly (ethylene glycol)‐poly (D, L‐lactide) blends for controlled release of paclitaxel. J Biomed Mater Res Part A. 2006;78(1):12–19. doi:10.1002/jbm.a.30684
   PubMedGoogle Scholar
• Rabanel J-M, Piec P-A, Landri S, Patten SA, Ramassamy C. Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability. J Control Release. 2020;328:679–695. doi:10.1016/j.jconrel.2020.09.042
   PubMed Web of Science ®Google Scholar
• Huang F-YJ, Chen W-J, Lee W-Y, S-T L, Lee T-W, J-M L. In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery. Int J Mol Sci. 2013;14(2):2862–2874. doi:10.3390/ijms14022862
   PubMed Web of Science ®Google Scholar
• Loureiro JA, Gomes B, Coelho MA, Carmo Pereira M, Rocha S. Targeting nanoparticles across the blood–brain barrier with monoclonal antibodies. Nanomedicine. 2014;9(5):709–722. doi:10.2217/nnm.14.27
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Delivery Rev. 2016;99(Pt A):28–51. doi:10.1016/j.addr.2015.09.012
   PubMed Web of Science ®Google Scholar
• Tehrani SF, Bernard-Patrzynski F, Puscas I, Leclair G, Hildgen P, Roullin VG. Length of surface PEG modulates nanocarrier transcytosis across brain vascular endothelial cells. Nanomedicine. 2019;16:185–194. doi:10.1016/j.nano.2018.11.016
   PubMed Web of Science ®Google Scholar
• Andaloussi SE, Lakhal S, Mäger I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Delivery Rev. 2013;65(3):391–397. doi:10.1016/j.addr.2012.08.008
   PubMed Web of Science ®Google Scholar
• Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Research support, Non-U.S. Gov’t Review. Cells. 2019;8(7):727. doi:10.3390/cells8070727
   PubMed Web of Science ®Google Scholar
• Pegtel DM, Gould SJ. Exosomes. Annu. Rev. Biochem. 2019;88(1):487–514. doi:10.1146/annurev-biochem-013118-111902
   PubMed Web of Science ®Google Scholar
• Lai RC, Yeo RW, Tan KH, Lim SK. Exosomes for drug delivery - a novel application for the mesenchymal stem cell. Review. Biotechnol. Adv. 2013;31(5):543–551. doi:10.1016/j.biotechadv.2012.08.008
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Research support, Non-U.S. Gov’t. Review. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.125
   PubMed Web of Science ®Google Scholar
• Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005;17(7):879–887. doi:10.1093/intimm/dxh267
   PubMed Web of Science ®Google Scholar
• Kang JY, Park H, Kim H, et al. Human peripheral blood‑derived exosomes for microRNA delivery. IntJ Mol Med. 2019;43(6):2319–2328. doi:10.3892/ijmm.2019.4150
   PubMed Web of Science ®Google Scholar
• Van den Boorn JG, Schlee M, Coch C, Hartmann G. SiRNA delivery with exosome nanoparticles. Nature Biotechnol. 2011;29(4):325–326. doi:10.1038/nbt.1830
   PubMed Web of Science ®Google Scholar
• Piffoux M, Nicolás-Boluda A, Mulens-Arias V, et al. Extracellular vesicles for personalized medicine: the input of physically triggered production, loading and theranostic properties. Adv Drug Delivery Rev. 2019;138:247–258. doi:10.1016/j.addr.2018.12.009
   PubMed Web of Science ®Google Scholar
• Amiri A, Bagherifar R, Ansari Dezfouli E, Kiaie SH, Jafari R, Ramezani R. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. J Transl Med. 2022;20(1):1–16. doi:10.1186/s12967-022-03325-7
   PubMed Web of Science ®Google Scholar
• Qu M, Lin Q, Huang L, et al. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease. J Control Release. 2018;287:156–166. doi:10.1016/j.jconrel.2018.08.035
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres JV, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7(2):88–95. doi:10.1016/0006-2952(61)90145-9
   PubMed Web of Science ®Google Scholar
• Rabanel J-M, Faivre J, Zaouter C, Patten SA, Banquy X, Ramassamy C. Nanoparticle shell structural cues drive in vitro transport properties, tissue distribution and brain accessibility in zebrafish. Biomaterials. 2021;277:121085. doi:10.1016/j.biomaterials.2021.121085
   PubMed Web of Science ®Google Scholar
• Koto T, Takubo K, Ishida S, et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol. 2007;170(4):1389–1397. doi:10.2353/ajpath.2007.060693
   PubMed Web of Science ®Google Scholar
• Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Research Support, U.S. Gov’t, P.H.S. Dev. Dyn. 1995;203(3):253–310. doi:10.1002/aja.1002030302
   PubMed Web of Science ®Google Scholar
• Cheng J, Gu Y-J, Wang Y, Cheng SH, Wong W-T. Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos. Int j Nanomed. 2011;2007–2021. doi:10.2147/IJN.S20145
   PubMed Web of Science ®Google Scholar
• Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 2002;248(2):307–318. doi:10.1006/dbio.2002.0711
   PubMed Web of Science ®Google Scholar
• Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nature Methods. 2012;9(7):676–682. doi:10.1038/nmeth.2019
   PubMed Web of Science ®Google Scholar
• Sutthapitaksakul L, Dass CR, Sriamornsak P. Donepezil—An updated review of challenges in dosage form design. J Drug Delivery Sci Technol. 2021;63:102549. doi:10.1016/j.jddst.2021.102549
   Web of Science ®Google Scholar
• van der Meel R, Fens MH, Vader P, Van Solinge WW, Eniola-Adefeso O, Schiffelers RM. Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release. 2014;195:72–85. doi:10.1016/j.jconrel.2014.07.049
   PubMed Web of Science ®Google Scholar
• Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm. 2008;364(2):298–327. doi:10.1016/j.ijpharm.2008.04.042
   PubMed Web of Science ®Google Scholar
• Jayaraj RL, Tamilselvam K, Manivasagam T, Elangovan N. Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model of Parkinson’s disease. J Mol Neurosci. 2013;51(3):863–870. doi:10.1007/s12031-013-0075-8
   PubMed Web of Science ®Google Scholar
• Chuo ST-Y, Chien JC-Y, Lai CP-K. Imaging extracellular vesicles: current and emerging methods. J Biomed Sci. 2018;25(1):1–10. doi:10.1186/s12929-018-0494-5
   PubMedGoogle Scholar
• Tong R, Coyle VJ, Tang L, Barger AM, Fan TM, Cheng J. Polylactide nanoparticles containing stably incorporated cyanine dyes for in vitro and in vivo imaging applications. Microsc Res Tech. 2010;73(9):901–909. doi:10.1002/jemt.20824
   PubMed Web of Science ®Google Scholar
• Zhu L, Li R, Jiao S, et al. Blood-brain barrier permeable chitosan oligosaccharides interfere with β-Amyloid aggregation and alleviate β-amyloid protein mediated neurotoxicity and neuroinflammation in a dose-and degree of polymerization-dependent manner. Mar Drugs. 2020;18(10):488. doi:10.3390/md18100488
   PubMed Web of Science ®Google Scholar
• Campbell F, Bos FL, Sieber S, et al. Directing nanoparticle biodistribution through evasion and exploitation of Stab2-dependent nanoparticle uptake. ACS nano. 2018;12(3):2138–2150. doi:10.1021/acsnano.7b06995
   PubMed Web of Science ®Google Scholar
• Beccaria K, Canney M, Bouchoux G, Puget S, Grill J, Carpentier A. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives. Neurosurg Focus. 2020;48(1):E10. doi:10.3171/2019.10.FOCUS19726
   PubMed Web of Science ®Google Scholar
• Almutairi M, Gong C, Xu YG, Chang Y, Shi H. Factors controlling permeability of the blood–brain barrier. Cell. Mol. Life Sci. 2016;73(1):57–77. doi:10.1007/s00018-015-2050-8
   PubMed Web of Science ®Google Scholar
• Rempe R, Cramer S, Qiao R, Galla H-J. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties. Cell Tissue Res. 2014;355(3):717–726. doi:10.1007/s00441-014-1819-7
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang H-X, C-P H, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149. doi:10.1016/j.biomaterials.2017.10.012
   PubMed Web of Science ®Google Scholar
• Li AJ, Zheng YH, Liu GD, Liu WS, Cao PC, Bu ZF. Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles. Mol Med Rep. 2015;11(4):3078–3086. doi:10.3892/mmr.2014.3017
   PubMed Web of Science ®Google Scholar
• Zhou R, Zhu L, Zeng Z, et al. Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer’s disease treatment and diagnosis. Bioeng Transl Med 2022;7(3):e10395. doi:10.1002/btm2.10395
   PubMed Web of Science ®Google Scholar
• Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nature Nanotechnol. 2021;16(7):748–759. doi:10.1038/s41565-021-00931-2
   PubMed Web of Science ®Google Scholar
• Xu J, Chen Y, Jiang X, Gui Z, Zhang L. Development of hydrophilic drug encapsulation and controlled release using a modified nanoprecipitation method. Processes. 2019;7(6):331. doi:10.3390/pr7060331
   Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. doi:10.1016/j.jconrel.2015.03.033
   PubMed Web of Science ®Google Scholar
• Al-Jipouri A, Almurisi SH, Al-Japairai K, Bakar LM, Doolaanea AA. Liposomes or Extracellular Vesicles: a Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery. Polymers. 2023;15(2):318. doi:10.3390/polym15020318
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215–223. doi:10.1016/j.yexmp.2008.12.004
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P. Physico-chemical stability of colloidal lipid particles. Biomaterials. 2003;24(23):4283–4300. doi:10.1016/S0142-9612(03)00331-4
   PubMed Web of Science ®Google Scholar
• Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood–brain barrier integrity and permeability. J Drug Targeting. 2004;12(9–10):635–641. doi:10.1080/10611860400015936
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood–brain barrier by nanoparticles. J Control Release. 2012;161(2):264–273. doi:10.1016/j.jconrel.2011.08.017
   PubMed Web of Science ®Google Scholar
• Goldblum D, Gygax M, Böhnke M, Garweg JG. In vitro toxicity of rivastigmine and donepezil in cells of epithelial origin. Ophthal Res. 2002;34(2):97–103. doi:10.1159/000048336
   PubMed Web of Science ®Google Scholar
• Das JR, Tizabi Y. Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells. Neurotox Res. 2009;16(3):194–204. doi:10.1007/s12640-009-9040-2
   PubMed Web of Science ®Google Scholar
• Kou L, Sun J, Zhai Y, He Z. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci. 2013;8(1):1–10. doi:10.1016/j.ajps.2013.07.001
   Google Scholar
• Yamamoto T, Kosaka N, Ochiya T. Latest advances in extracellular vesicles: from bench to bedside. Sci Technol Adv Mater. 2019;20(1):746–757. doi:10.1080/14686996.2019.1629835
   PubMed Web of Science ®Google Scholar
• Lee M, Ban -J-J, Yang S, Im W, Kim M. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer’s disease. Brain Res. 2018;1691:87–93. doi:10.1016/j.brainres.2018.03.034
   PubMed Web of Science ®Google Scholar
• Bonafede R, Scambi I, Peroni D, et al. Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp Cell Res 2016;340(1):150–158. doi:10.1016/j.yexcr.2015.12.009
   PubMed Web of Science ®Google Scholar
• Sun T, Ding Z-X, Luo X, Liu Q-S, Cheng Y, Hassanzadeh K. Blood exosomes have neuroprotective effects in a mouse model of Parkinson’s disease. Oxid Med Cell Longev. 2020;2020:1–14. doi:10.1155/2020/3807476
   Web of Science ®Google Scholar
• Feng D, Zhao WL, Ye YY, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675–687. doi:10.1111/j.1600-0854.2010.01041.x
   PubMed Web of Science ®Google Scholar
• Tehrani SF, Rabanel J-M, Legeay S, et al. Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells. Eur. J. Pharm. Biopharm. 2022;174:155–166. doi:10.1016/j.ejpb.2022.04.003
   PubMed Web of Science ®Google Scholar
• Morad G, Carman CV, Hagedorn EJ, et al. Tumor-derived extracellular vesicles breach the intact blood–brain barrier via transcytosis. ACS nano. 2019;13(12):13853–13865. doi:10.1021/acsnano.9b04397
   PubMed Web of Science ®Google Scholar
• Yuan D, Zhao Y, Banks WA, et al. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials. 2017;142:1–12. doi:10.1016/j.biomaterials.2017.07.011
   PubMed Web of Science ®Google Scholar
• Kur I-M, Prouvot P-H, Fu T, et al. Neuronal activity triggers uptake of hematopoietic extracellular vesicles in vivo. PLoS biol. 2020;18(3):e3000643. doi:10.1371/journal.pbio.3000643
   PubMed Web of Science ®Google Scholar
• Cascallar M, Alijas S, Pensado-López A, et al. What zebrafish and nanotechnology can offer for cancer treatments in the age of personalized medicine. Cancers. 2022;14(9):2238. doi:10.3390/cancers14092238
   PubMed Web of Science ®Google Scholar
• Matsuda A, Moirangthem A, Angom RS, et al. Safety of bovine milk derived extracellular vesicles used for delivery of RNA therapeutics in zebrafish and mice. J Appl Toxicol. 2020;40(5):706–718. doi:10.1002/jat.3938
   PubMed Web of Science ®Google Scholar
• Gritsman K, Talbot WS, Schier AF. Nodal signaling patterns the organizer. Development. 2000;127(5):921–932. doi:10.1242/dev.127.5.921
   PubMed Web of Science ®Google Scholar
• Trikić MZ, Monk P, Roehl H, Partridge LJ, Kanellopoulos J. Regulation of zebrafish hatching by tetraspanin cd63. PLoS One. 2011;6(5):e19683. doi:10.1371/journal.pone.0019683
   PubMed Web of Science ®Google Scholar
• Best JD, Berghmans S, Hunt JJ, et al. Non-associative learning in larval zebrafish. Neuropsychopharmacology. 2008;33(5):1206–1215. doi:10.1038/sj.npp.1301489
   PubMed Web of Science ®Google Scholar
• Svoboda KR, Vijayaraghavan S, Tanguay RL. Nicotinic receptors mediate changes in spinal motoneuron development and axonal pathfinding in embryonic zebrafish exposed to nicotine. J Neurosci. 2002;22(24):10731–10741. doi:10.1523/JNEUROSCI.22-24-10731.2002
   PubMed Web of Science ®Google Scholar
• Fitch WM. Distinguishing homologous from analogous proteins. Syst Zool. 1970;19(2):99–113. doi:10.2307/2412448
   PubMedGoogle Scholar
• Ibach B, Haen E. Acetylcholinesterase inhibition in Alzheimer’s Disease. Curr Pharm Des. 2004;10(3):231–251. doi:10.2174/1381612043386509
   PubMed Web of Science ®Google Scholar
• Li Y, Chen T, Miao X, et al. Zebrafish: a promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier. Pharmacol Res. 2017;125:246–257. doi:10.1016/j.phrs.2017.08.017
   PubMed Web of Science ®Google Scholar
• Jeong J-Y, Kwon H-B, Ahn J-C, et al. Functional and developmental analysis of the blood–brain barrier in zebrafish. Brain Res Bull. 2008;75(5):619–628. doi:10.1016/j.brainresbull.2007.10.043
   PubMed Web of Science ®Google Scholar
• Lu W, Wan J, She Z, Jiang X. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release. 2007;118(1):38–53. doi:10.1016/j.jconrel.2006.11.015
   PubMed Web of Science ®Google Scholar
• Yang T, Martin P, Fogarty B, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32(6):2003–2014. doi:10.1007/s11095-014-1593-y
   PubMed Web of Science ®Google Scholar
• Qi Y, Guo L, Jiang Y, Shi Y, Sui H, Zhao L. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles. Drug Delivery. 2020;27(1):745–755. doi:10.1080/10717544.2020.1762262
   PubMed Web of Science ®Google Scholar
• Nakano M, Nagaishi K, Konari N, et al. Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes. Sci Rep. 2016;6(1):24805. doi:10.1038/srep24805
   PubMedGoogle Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein Corona with possible implications for biological impacts. Proc Natl Acad Sci. 2008;105(38):14265–14270. doi:10.1073/pnas.0805135105
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter A, Andresen T. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol. 2012;52(1):481–503. doi:10.1146/annurev-pharmtox-010611-134623
   PubMedGoogle Scholar
• Grenier P, de Oliveira Viana IM, Lima EM, Bertrand N. Anti-polyethylene glycol antibodies alter the protein Corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo. J Control Release. 2018;287:121–131. doi:10.1016/j.jconrel.2018.08.022
   PubMed Web of Science ®Google Scholar
• Saadati R, Dadashzadeh S, Abbasian Z, Soleimanjahi H. Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug. Pharm Res. 2013;30(4):985–995. doi:10.1007/s11095-012-0934-y
   PubMed Web of Science ®Google Scholar
• Verhoef JJ, Carpenter JF, Anchordoquy TJ, Schellekens H. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discovery Today. 2014;19(12):1945–1952. doi:10.1016/j.drudis.2014.08.015
   PubMed Web of Science ®Google Scholar
• Yang Q, Lai SK. Anti‐PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev. 2015;7(5):655–677. doi:10.1002/wnan.1339
   Google Scholar
• Wang Z, Zhang S, Tong Z, Li L, Wang G, Fugmann SD. Maternal transfer and protective role of the alternative complement components in zebrafish Danio rerio. PLoS One. 2009;4(2):e4498. doi:10.1371/journal.pone.0004498
   PubMed Web of Science ®Google Scholar